Regulatory and commercial advisory
Regulatory framework for medical cannabis in Chile and the region. Legal structuring, market-entry model assessment, regulatory due diligence.
TrazagrowHealth Canada GPPLey 20.000Ley 20.500REPROCANNIRCCAANVISAINVIMA
Consulting and technology for the medical cannabis industry in Latin America.
CannaTech SpA supports operators, associations, labs and investors in the development of regulated activities in the sector. Commercial and regulatory advisory, technology platform development, and operational facilitation across Chile, Argentina, Uruguay, Brazil, Colombia, Paraguay and Mexico.
Three lines of work
Vertical technology
Traceability, compliance and operations platforms. Trazagrow in production in three countries.
Market development and investment
Opportunity assessment, commercial matchmaking between international operators and local actors, investment analysis.
Operating in seven countries, one team.
Seven distinct regulatory frameworks. One coherent reading.
We are not a generalist consultancy. We are a focused team.
- Operational knowledge of the Chilean and regional regulatory framework.
- In-house technical capability — we develop software internally.
- Independence and rigor — we do not represent third-party products.
- Regional network — operations and ties in Chile, Argentina and Uruguay; expansion to Brazil, Colombia, Paraguay and Mexico.
seed-to-sale · LatAm
Trazagrow — seed-to-sale platform for medical cannabis in LatAm.
CannaTech is part of the Trazagrow project, a seed-to-sale traceability SaaS platform for medical cannabis associations and operators in Latin America. Immutable records, native regulatory compliance in Chile, Argentina and Uruguay, expansion to Brazil and Colombia in 2026.
Latest posts
International PolicyInternational · Dec 30, 2025 · 8 min read
Federal Cannabis Reclassification in the U.S.: What Changed in April 2026 and What It Means for LatAm
On April 23, 2026, the DOJ moved FDA-approved cannabis pharmaceuticals and state-licensed medical products to Schedule III. It legalizes nothing new, but opens three doors: Section 280E, banking, and research. Implications for Latin American exporters and investors.
Read article →RegulationBrazil · Dec 17, 2025 · 9 min read
Brazil's new regulatory framework: how to read RDCs 1.012, 1.013, 1.014 and 1.015 of 2026
In January/February 2026 ANVISA published four RDCs that replace the landmark RDC 327/2019 and regulate, for the first time, domestic production, scientific research and non-profit patient associations. RDC 660/2022 remains in force but under review.
Read article →International PolicyInternational · 3 dic 2025 · 7 min read
República Checa: cómo el quinto país europeo con legalización adulta puede ordenar el debate regional
El 1 de enero de 2026 entró en vigor la legalización checa de uso adulto: hasta 3 plantas y 100 g en domicilio para mayores de 21 años. Contraste con Alemania e implicancias para el mercado europeo de medicinal.
Available in Spanish — translation in progressRead article →Are you evaluating an operation, an investment or a technology development in the sector? Let's talk.